Metalyse - supply shortage

Resolved

tenecteplase

Shortage information

The shortage affecting Metalyse has been resolved and the information and recommendations which were issued during the shortage no longer apply.

Key facts

• Medicines affected:
  Metalyse
• Supply shortage status:
  Resolved
• International non-proprietary name (INN) or common name:
  tenecteplase
• Therapeutic area (MESH):
  Myocardial Infarction
• Pharmaceutical forms affected:
  Powder and solvent for solution for injection
• Strengths affected:
  • 8,000 units (40 mg)
  • 10,000 units (50 mg)
• Availability of alternatives:
  Yes

Key dates

• First published:
  23/09/2022
• Last updated:
  11/05/2023